Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Double-Blind Study of the Incidence, Severity, and Risk Factors of Clenching Induced by Sugammadex During Neuromuscular Blockade Reversal

NCT06962007 is registered in ClinicalTrials.gov with Wonkwang University Hospital as lead sponsor.

NCT NCT06962007
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06962007 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Double-Blind Study of the Incidence, Severity, and Risk Factors of Clenching Induced by Sugammadex During Neuromuscular Blockade Reversal
Lead sponsor
Wonkwang University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
July 1, 2025
Completion date
October 14, 2026
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia, general, masseter muscle spasm, monitoring, intraoperative, neuromuscular blockade reversal agent, perioperative complications, sugammadex